Legal Representation
Attorney
John W. Olivo, Jr.
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 11, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 11, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jul 11, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Mar 27, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 27, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 22, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 22, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 22, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 22, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 25, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 25, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 25, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 24, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 23, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 23, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 23, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 23, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 21, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 29, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 28, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 2, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medical testing kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, viral infections, mononucleosis, streptococcal infections, and sexually transmitted diseases (STDs), and sexually transmitted infections (STIs); pregnancy and fertility test kits for home use; drug testing kits comprised of medical reagents and assays that test for the presence of drugs; antibody test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in detection of antibodies; medical diagnostic assays for testing body fluids for the detection of infectious diseases; chemical, biochemical and biological reagents for medical and medical diagnostic purposes; diagnostic reagents for clinical medical and medical diagnostic purposes
First Use Anywhere:
Jun 30, 2020
First Use in Commerce:
Feb 21, 2021
Class 035
Wholesale distributorships featuring medical testing supplies; product demonstration services in the field of medical diagnostic testing; computerized database management of diagnostic testing and results; distributorship services to hospitals, drug stores, pharmacies, clinics and other healthcare providers in the field of medical medical testing supplies and pharmaceuticals; business management marketing and operations consulting services for drugstores, hospitals, clinics, alternate care centers, and pharmacies; on-line product catalog, namely, online ordering services featuring a full line of pharmaceuticals, medical, surgical and laboratory supplies and equipment; consulting services in the field of business marketing and business operations in the medical field
First Use Anywhere:
Jun 30, 2020
First Use in Commerce:
Feb 21, 2021
Class 044
Medical testing for diagnostic or treatment purposes; concierge medicine services, namely, on-site medical polymerase chain reaction testing for diagnostic or treatment purposes; concierge medicine services, namely, on-site medical rapid diagnostic testing for diagnostic or treatment purposes; on-site medical testing for diagnostic or treatment purposes at the workplace and events; consulting services in the field of medical care in the nature of medical testing for diagnostic or treatment purposes and operations
First Use Anywhere:
Jun 30, 2020
First Use in Commerce:
Feb 21, 2021
Additional Information
Design Mark
The mark consists of the stylized wording "LINEAR DIAGNOSTICS" in black to the right of the stylized letter "L" in white imposed on a miscellaneous polygonal shape in teal and black. The remaining color white in the mark represents background and/or transparent areas and is not claimed as a feature of the mark.
Color Claim
The color(s) teal, black, and white is/are claimed as a feature of the mark.
Classification
International Classes
005
035
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"DIAGNOSTICS"